Skip to content

Advisory Board on Cancer, Infertility and Pregnancy

Advisory Board on Cancer, Infertility and Pregnancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04904263
Acronym
ABCIP
Enrollment
100
Registered
2021-05-27
Start date
2021-05-22
Completion date
2024-05-22
Last updated
2021-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Cancer in Pregnancy, Fertility Preservation, Pregnancy

Keywords

Cancer in Pregnancy, Fertility preservation

Brief summary

The Advisory Board on Cancer, Infertility and Pregnancy provides a platform where physicians from all over the world can request recommendations regarding the medical care of pregnant women diagnosed with cancer or regarding fertility preservation. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards. To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Detailed description

The Advisory Board on Cancer, Infertility and Pregnancy (ABCIP)-platform will be a web-based platform where clinicians from all over the world can request advice from a group of experts on the field of Cancer and Pregnancy. The platform will contain different national advisory boards, with their own coordinator and members, as well as an overarching international advisory board with an international coordinator and members from different national boards. Clinicians can fill in a format (attached) requesting for advice, using only pseudonymized patient data after agreeing a disclaimer: All information filled in in the 'request advice' format needs to be regarded as anonymous or pseudonymous data. We recommend you to inform your patient and ask for approval when needed, based on the rules and regulations applicable in your country. The filled out request will be sent to the specific national board of their own country, and if no national board is available, to the overarching international board. . To investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters.

Interventions

None listed

Sponsors

Kom Op Tegen Kanker
CollaboratorOTHER
European Research Council
CollaboratorOTHER
University Hospital, Gasthuisberg
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Pregnant women with a cancer diagnosis * Women with a fertility related question after cancer diagnosis * Postpartum cancer diagnosis * Cancer treatment during pregnancy

Design outcomes

Primary

MeasureTime frameDescription
The impact of an international advisory board on cancer in pregnancy1 yearTo investigate the impact of this platform, a year after its launch, data regarding the incoming requests will be extracted from the website, as well as all recommendation letters. All requesting physicians will be asked to complete a survey including their experiences with the ABCIP, to what amount they followed the given recommendations and the outcomes of mother (and child)

Countries

Belgium

Contacts

Primary ContactFrederic Amant, MD,PhD
frederic.amant@uzleuven.be+32 16 344252
Backup ContactJoosje Heimovaara, MD
joosje.heimovaara@uzleuven.be+32 16 344252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026